HACKENSACK, N.J., (April 12, 2010) John Theurer Cancer Center at Hackensack University Medical Center will host a hematological malignancies conference for physicians and patients on Friday, April 23 and Saturday, April 24. The event, entitled "Current and Innovative Modalities in the Management of Hematological Malignancies", is part of John Theurer Cancer Center's commitment to provide both healthcare professionals as well as patients with an update on the newest advances in the field of blood-borne cancers.
Hematologic malignancies include lymphoma, multiple myeloma, and leukemia, and affect an estimated 140,000 patients a year in the United States. This number represents approximately 10 percent of all new cancer diagnoses. The incidence of these cancers has been steadily rising, up nearly 20 percent in the last six years alone.
All-Day Symposium for Physicians: Friday, April 23
On April 23rd, the John Theurer Cancer Center will bring oncology experts from leading cancer institutions, including the Mayo Clinic, Rochester, Dana Farber Cancer Center Institute in Boston, Fred Hutchinson Cancer Research Center in Seattle, Memorial Sloan Kettering Cancer Center, University of Nebraska Medical Center in Omaha and Robert H. Lurie Comprehensive Cancer Center in Chicago as well as experts from Germany, to discuss important trends in blood-borne cancers to enhance patient care and to incorporate novel therapies through clinical trials. Registration and food are complimentary, and attendees can receive up to 6.5 continuing medical education (CME) credits.
"John Theurer Cancer Center strives to provide the best continuing education programs so that we can further advance cancer treatments and tackle the most complicated cases," Andrew Pecora, M.D., F.A.C.P., C.P.E., Chairman and Executive Administrative Director, John Theurer Cancer Center. "We are proud to bring high-caliber medical leaders to share their expertise with ou
|Contact: Amy Leahing|
John Theurer Cancer Center